Skip to content

Development of imaging evaluation and intelligent diagnosis system for pituitary adenoma consistency and invasiveness

Development of imaging evaluation and intelligent diagnosis system for pituitary adenoma consistency and invasiveness

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047614
Enrollment
Unknown
Registered
2021-06-20
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pituitary Adenoma

Interventions

Gold Standard:1 Intraoperative evaluation, histopathological and immunohistochemical diagnosis
2 Mannual segmentation by two radiologists.
consistency,&#32
invasiveness
artificial&#32

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years, gender is not limited; 2. Patients diagnosed as pituitary adenoma by clinical data, and finally confirmed by pathological staining as pituitary adenoma; 3. The vital signs are stable, and the MR scan can be completed with good cooperation; 4. There is no obvious bleeding in the tumor that can cause image deformation, and there is no metal foreign body in the head; 5. Unconscious obstacles, normal communication skills; 6. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Incomplete clinical and imaging data; 2. The patient has expressly refused to participate in any scientific clinical trial; 3. Has recently participated in other clinical research trials.

Design outcomes

Primary

MeasureTime frame
area under the curve;sensitivity;specifity;accuracy;

Countries

China

Contacts

Public ContactYao Zhenwei
zwyao@fudan.edu.cn+86 13262631100

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026